Reverse use-dependent QT prolongation during infusion of nifekalant in a case of recurrent ventricular tachycardia with old myocardial infarction

Journal of Electrocardiology

Volumn 34, Issue 1, 2001, Pages 77-80

  Shiga, T ^a   Ando, S ^a   Suzuki, T ^a   Matsuda, N ^a   Kasanuki, H ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Nifekalant; Potassium channel; QT interval; Use dependence; Ventricular tachycardia

Indexed keywords

METOPROLOL; NIFEKALANT; POTASSIUM CHANNEL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PRIORITY JOURNAL; QT INTERVAL;

EID: 0035093746     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1054/jelc.2001.22063     Document Type: Article

References (11)

1. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes
2. Antiarrhythmic effects of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia
3. Electrophysiological effect of MS-551 in humans: A class III antiarrhythmic agent
4. Efficacy of intravenous doses of MS-551 for drug-resistant sustained ventricular tachycardia
5. Phase 1 study of MS-551 (1): A single intravenous injection study
6. Emerging class III antiarrhythmic agents: Mechanism of action and proarrhythmic potential
7. + current in rabbit ventricular myocytes
8. Electropharmacology of nifekalant, a new class III antiarrhythmic drug
9. Assessment of reverse use-dependent blocking action of class III antiarrhythmic drugs by 24-hour Holter electrocardiography
10. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes
11. Diurnal pattern of QTc interval: How long is prolonged? Possible relation to circadian triggers of cardiovascular events